Article Details

Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth ...

Retrieved on: 2022-10-03 11:17:35

Tags for this article:

Click the tags to see associated articles and topics

Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth .... View article details on hiswai:

Excerpt

03.10.2022 - Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to acquire Lexington, Mass.

Article found on: www.wallstreet-online.de

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up